Kimryn Rathmell: Engaging and empowering patients in cancer research is our responsibility

Kimryn Rathmell shared on X/Twitter:

“Engaging and empowering patients in cancer research is our responsibility. It’s crucial that the Clinical Trials system addresses and eliminates inequities, which is also a key goal of the National Cancer Plan.”

Source: Kimryn Rathmell/X

Dr. Kimryn Rathmell is a distinguished leader and researcher in the field of kidney cancer. Specializing in the research and treatment of complex and hereditary kidney cancers. 

She has held leadership positions with organizations such as the American Society of Clinical Oncology and the American Society for Clinical Investigation, she has been elected to esteemed academies including the Association of American Physicians, the American Academy of Arts and Sciences, and the National Academy of Medicine.

Currently serving as the director of the National Cancer Institute, Dr. Rathmell continues to lead research initiatives and advance the understanding and treatment of kidney cancer, ultimately improving the lives of patients worldwide.